Edmund Ingham

Biotechnology Edmund Ingham GILD GILD:CA Uncategorized VIR

Vir Biotechnology: Up On Prostate Data And Astellas Deal – I’m (Long-Term) Bullish

Feb 24, 2026

Biotechnology Edmund Ingham Uncategorized VNDA

Vanda Pharmaceuticals: Soaring On Bysanti Approval, But You Shouldn’t Feel Dizzy

Feb 23, 2026

Biotechnology Edmund Ingham KYMR Uncategorized

Kymera Therapeutics: The More This Biotech Spends, The Higher Its Valuation Rises

Feb 20, 2026

« Previous Page